Merck (NYSE:MRK) narrowed its full-year earnings outlook while announcing its second quarter results today. The company revealed that an international cyber attack, which hit the drugmaker in June, halted some of its manufacturing operations.
While touting its second quarter financial results, Merck said that it doesn’t yet fully comprehend the magnitude of the disruption caused by the cyber attack and that it is still restoring its operations.
Get the full story at our sister site, Drug Delivery Business News.
The post Cyber attack stalls manufacturing for Merck, narrows outlook appeared first on MassDevice.